US11166971B2ActiveUtilityA1

Methods of treating COVID-19 infection

Assignee: HAZAN SABINEPriority: Mar 23, 2020Filed: Dec 18, 2020Granted: Nov 9, 2021
Est. expiryMar 23, 2040(~13.7 yrs left)· nominal 20-yr term from priority
Inventors:Sabine Hazan
A61K 31/4706A61K 33/30A61P 31/14A61K 31/7052A61K 31/593A61K 31/375
91
PatentIndex Score
4
Cited by
94
References
3
Claims

Abstract

A method of treating an individual infected with COVID-19, the method comprising the steps of: providing an individual infected with COVID-19; administering five antimicrobials to the individual, wherein the antimicrobials comprise: hydroxychloroquine; azithromycin; vitamin C; vitamin D; and zinc; and monitoring the individuals condition over a pre-determined period of time to determine whether the individual is no longer infected with COVID-19.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method of treating an individual infected with COVID-19, the method comprising the steps of:
 a) providing an individual infected with COVID-19; 
 b) administering to the individual, on day 1:
 i) two doses of 200 mg of hydroxychloroquine; 
 ii) one dose of 500 mg of azithromycin; 
 iii) one dose of 3,000 mg of vitamin C; 
 iv) one dose of 3,000 IU of vitamin D; and 
 v) one dose of 50 mg of zinc; 
 
 c) administering daily to the individual, on days 2 to 5:
 i) two doses of 200 mg of hydroxychloroquine; 
 ii) one dose of 250 mg of azithromycin; 
 iii) one dose of 3,000 mg of vitamin C; 
 iv) one dose of 3,000 IU of vitamin D; and 
 v) one dose of 50 mg of zinc; and 
 
 d) administering daily to the individual, on days 6 to 10:
 i) two doses of 200 mg of hydroxychloroquine; 
 ii) one dose of 3,000 mg of vitamin C; 
 iii) one dose of 3,000 IU of vitamin D; and 
 iv) one dose of 50 mg of zinc; and 
 
 e) monitoring the individuals condition over a pre-determined period of time to determine whether the individual is no longer infected with COVID-19. 
 
     
     
       2. The method of  claim 1 , wherein step d) of administering on days 6 to 10 further comprises administering one dose of 250 mg of azithromycin. 
     
     
       3. The method of  claim 1 , wherein the two doses of hydroxychloroquine in step b), step c), and step d) are administered as a single daily dose.

Join the waitlist — get patent alerts

Track US11166971B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.